acut
respiratori
tract
infect
arti
public
health
issu
common
reason
doctor
visit
hospit
young
children
major
contributor
morbid
mortal
age
group
popul
aramburo
et
al
bezerra
et
al
sung
et
al
et
al
virus
one
major
caus
arti
accur
time
identif
respons
viral
pathogen
would
delin
epidemiolog
clinic
signific
reduc
unnecessari
antimicrobi
use
et
al
past
detect
respiratori
virus
reli
viru
isol
cell
cultur
antigen
test
howev
addit
influenza
viru
flu
respiratori
synciti
viru
rsv
adenoviru
adv
parainflenza
viru
piv
increas
number
newli
discov
virus
human
metapneumoviru
hmpv
human
coronavirus
hcov
human
bocaviru
hbov
recogn
possibl
viral
pathogen
arti
virus
routin
cultiv
clinic
laboratori
molecular
detect
util
high
throughput
multiplex
pcr
assay
develop
wide
appli
past
decad
freymuth
et
al
lee
et
al
khami
et
al
use
molecular
detect
technolog
simultan
detect
broad
spectrum
respiratori
virus
feasibl
await
valid
better
understand
role
diagnos
respiratori
infect
studi
aim
profil
virus
caus
acut
respiratori
infect
children
admit
hospit
central
taiwan
use
convent
viru
isol
xtag
respiratori
viru
panel
rvp
fast
assay
investig
signific
viral
studi
conduct
prospect
chang
bing
show
chwan
memori
hospit
taiwan
may
juli
children
year
age
admit
pediatr
depart
ward
fever
ari
symptom
elig
enrol
inclus
criteria
within
day
hospit
receiv
rapid
influenza
flu
test
neg
flu
teat
enrol
rapid
test
influenza
b
antigen
frequent
appli
routin
clinic
practic
fever
sampl
day
patient
malign
metabol
genet
diseas
immunodefici
exclud
protocol
approv
institut
review
board
chang
bing
show
chwan
memori
hospit
inform
consent
form
sign
parent
guardian
obtain
enrol
patient
two
sequenti
throat
swab
taken
pediatrician
physician
assist
place
liquid
transport
medium
copan
brescia
itali
one
sampl
subject
molecular
viral
detect
convent
viral
cultur
sampl
molecular
detect
store
batch
analysi
demograph
data
clinic
featur
laboratori
result
enrol
patient
collect
analyz
medic
chart
review
nucleic
acid
extract
stock
clinic
sampl
use
qiaamp
viral
rnadna
mini
kit
qiagen
valencia
ca
usa
accord
manufactur
instruct
extract
dna
rna
elut
elut
buffer
store
analys
commerci
kit
xtag
rvp
fast
assay
version
luminex
molecular
diagnost
inc
toronto
canada
use
respiratori
viral
detect
kit
allow
simultan
screen
common
respiratori
viral
subtyp
target
includ
influenza
viru
flu
addit
subtyp
posit
specimen
subtyp
influenza
b
viru
flu
b
respiratori
syncyti
viru
rsv
type
b
human
coronavirus
hcov
parainfluenza
virus
piv
type
human
metapneumoviru
hmpv
picornavirus
includ
rhinovirus
enterovirus
rvev
human
bocaviru
hbov
adenoviru
adv
assay
includ
rna
bacteriophag
intern
extractioninhibit
control
dna
bacteriophag
lambda
amplif
assay
perform
control
carri
use
xmap
instrument
luminex
molecular
diagnost
inc
analyz
tda
rvp
fast
softwar
version
abbott
molecular
continu
variabl
analyz
use
independ
one
way
anova
categor
variabl
test
comparison
less
consid
statist
signific
odd
ratio
confid
interv
ci
antibiot
usag
intens
care
hospit
calcul
multivari
logist
regress
statist
analys
carri
spss
softwar
packag
paw
statist
ibm
corpor
somer
ny
two
hundr
sixteen
febril
children
hospit
acut
respiratori
infect
enrol
may
juli
obtain
inform
consent
parent
guardian
overal
demograph
data
laboratori
clinic
find
final
etiolog
pathogen
determin
rvp
shown
tabl
figur
mean
age
year
sex
ratio
f
mean
age
significantli
lower
acut
bronchiol
group
year
p
clinic
diagnos
includ
upper
respiratori
tract
infect
acut
tonsil
acut
bronchiol
lower
respiratori
tract
infect
lrti
common
clinic
present
descend
order
cough
rhinorrhea
wheez
gastrointestin
symptom
mean
durat
hospit
stay
day
laboratori
find
differ
clinic
categori
gener
similar
overal
mean
white
blood
cell
count
wbc
neutrophil
count
serum
protein
crp
level
mgdl
crp
level
significantli
higher
acut
tonsil
group
p
overal
percentag
antibiot
administr
hospit
stay
vari
clinic
group
tabl
infect
identifi
case
use
antibiot
one
salmonella
bacteremia
three
urinari
tract
infect
four
case
exclud
calcul
risk
factor
antibiot
usag
potenti
risk
factor
relat
higher
rate
antibiot
use
includ
intens
care
clinic
diagnos
laboratori
analysi
white
cell
count
crp
level
viral
analyz
logist
regress
signific
factor
shown
order
crp
p
odd
ratio
ci
lrti
group
includ
acut
bronchiol
p
odd
ratio
ci
viral
group
p
odd
ratio
ci
fever
persist
day
admiss
p
odd
ratio
ci
use
xtag
rvp
fast
assay
least
one
viral
pathogen
identifi
patient
distribut
singl
viral
etiolog
descend
order
rvev
rsv
adv
piv
flu
b
flu
hmv
hcov
hbov
percentag
viral
etiolog
clinic
categori
shown
figur
picornaviru
rvev
predomin
viru
urti
group
rank
second
tonsil
bronchiol
group
adenoviru
predomin
tonsil
group
rsv
viru
frequent
detect
bronchiol
group
contrast
specimen
show
posit
result
convent
viral
cultur
wherea
least
one
viral
pathogen
could
found
specimen
combin
cell
cultur
rvp
fast
assay
data
perform
two
assay
method
summar
tabl
ii
good
agreement
detect
adv
enteroviru
flu
gener
rvp
fast
assay
detect
pathogen
convent
viral
isol
vs
occasion
fail
detect
flu
b
sensit
specif
rsv
sensit
specif
piv
clinic
strain
sensit
specif
viral
detect
rate
convent
viral
isol
significantli
higher
urti
lrti
vs
p
rvp
fast
assay
assess
influenc
sampl
time
reduct
viral
load
day
hospit
report
franz
et
al
detect
rate
rvp
fast
assay
convent
cell
cultur
analyz
viral
detect
rate
rvp
fast
assay
convent
cell
cultur
static
differ
time
sampl
less
day
hospit
admiss
greater
day
p
fig
hand
factor
includ
age
gender
bodi
temperatur
sampl
day
affect
viral
detect
rate
either
method
p
one
viru
detect
case
frequent
detect
virus
picornaviru
rvev
adv
hmpv
common
viral
pair
advpicornaviru
n
n
signific
differ
term
clinic
symptom
sever
laboratori
find
patient
singl
multipl
viral
infect
tabl
iii
except
percentag
rhinorrhea
vs
p
percentag
receiv
antibiot
vs
p
although
signific
differ
intens
care
singl
multipl
viral
infect
group
p
risk
factor
contribut
intens
care
age
year
p
odd
ratio
ci
presenc
dyspnea
p
odd
ratio
ci
respect
acut
respiratori
infect
lead
caus
hospit
morbid
children
profil
respiratori
viral
infect
expand
advanc
molecular
diagnosi
present
studi
conduct
cross
section
surveil
viral
pathogen
children
admit
arti
commun
hospit
rural
area
central
taiwan
enrol
case
least
one
viral
etiolog
could
identifi
half
case
combin
result
commerci
multiplex
nat
assay
convent
cell
cultur
result
line
previou
studi
identifi
viral
etiolog
case
ren
et
al
niang
et
al
shafik
et
al
marcon
et
al
rhedin
et
al
respiratori
virus
analyz
three
common
pathogen
descend
order
rvev
rsv
adv
viral
uncommon
common
viral
pair
adv
rvev
n
viral
detect
rate
upper
lower
respiratori
infect
compar
studi
wherea
ambrosioni
et
al
report
lower
rate
lower
respiratori
infect
pediatr
popul
ambrosioni
et
al
discrep
might
reflect
differ
profil
respiratori
virus
studi
popul
andor
differ
sensit
andor
limit
viral
detect
techniqu
appli
although
rsv
report
common
viru
detect
mani
investig
especi
children
year
old
bonzel
et
al
bezerra
et
al
et
al
et
al
studi
use
molecular
diagnost
found
rvev
common
viru
agreement
observ
stress
preval
import
picornaviru
upper
lower
respiratori
tract
infect
fabbiani
et
al
iwan
et
al
guerrier
et
al
renoi
et
al
furthermor
rhinoviru
belong
rvev
infect
demonstr
associ
sever
bronchiol
ricart
et
al
acut
tonsil
find
consist
hsieh
et
al
adenoviru
enteroviru
two
common
viral
etiolog
account
half
known
pathogen
hsieh
et
al
viral
frequent
encount
childhood
arti
studi
popul
predomin
viral
pathogen
vari
differ
studi
bharaj
et
al
et
al
kouni
et
al
clinic
signific
remain
controversi
present
studi
differ
infect
singl
multipl
pathogen
signific
term
clinic
present
sever
laboratori
result
except
higher
rate
rhinorrhea
use
antibiot
although
studi
found
multipl
viral
infect
associ
higher
fever
higher
rate
hospit
sever
diseas
frequent
use
antibiot
calvo
et
al
kouni
et
al
find
consist
previou
studi
presenc
multipl
pathogen
show
associ
sever
clinic
manifest
martin
et
al
rhedin
et
al
convent
cell
cultur
gener
abl
allow
time
manag
respiratori
tract
infect
nucleic
acid
amplif
platform
becam
prefer
tool
detect
respiratori
pathogen
advantag
swift
high
diagnost
frequenc
specif
sever
multiplex
test
current
avail
includ
xtag
rvp
fast
assay
use
studi
respiratori
virus
perform
xtag
rvp
fast
assay
compar
superior
real
time
pcr
convent
method
gadsbi
et
al
gharabaghi
et
al
present
studi
inpati
identifi
case
singl
viral
pathogen
xtag
rvp
fast
assay
addit
howev
reduc
sensit
detect
adv
flu
b
piv
hcov
xtag
rvp
fast
assay
especi
low
viral
concentr
requir
care
interpret
accord
studi
gharabaghi
et
al
pillet
et
al
optim
sampl
condit
demonstr
unlik
cell
cultur
viral
detect
rate
xtag
rvp
fast
assay
influenc
sampl
date
patient
admiss
reduct
viral
load
day
hospit
may
due
clinic
improv
may
contribut
reduc
rate
viral
detect
xtag
rvp
fast
assay
sampl
delay
franz
et
al
optim
viral
detect
recommend
sampl
collect
within
day
symptom
onset
studi
limit
major
limit
studi
select
bia
patient
posit
flu
antigen
test
exclud
therefor
real
rate
influenza
infect
would
underestim
still
detect
flu
flu
b
infect
studi
mostli
among
uri
group
sampl
time
vari
day
follow
admiss
posit
viral
detect
rate
influenc
progress
declin
viral
load
amelior
test
sampl
cell
cultur
molecular
detect
method
period
studi
long
enough
investig
season
variat
enrol
sampl
size
moder
determin
impact
individu
type
respiratori
viru
clinic
sever
studi
conduct
rural
hospit
viral
preval
pattern
shown
differ
urban
pediatr
popul
gern
et
al
find
viral
distribut
profil
lrti
group
similar
southern
taiwan
differ
northern
taiwan
sung
et
al
chou
et
al
respect
lrti
rsv
evrv
equal
role
studi
addit
studi
popul
enrol
critic
immunocompromis
patient
conclus
studi
provid
background
viral
epidemiolog
children
hospit
febril
ari
hospit
picornavirs
rsv
adv
frequent
detect
virus
viral
frequent
observ
associ
clinic
diseas
sever
introduct
molecular
detect
method
conduct
earli
admiss
benefici
earli
identif
caus
viral
pathogen
even
molecular
respiratori
viral
diagnost
techniqu
broaden
understand
etiolog
arti
profil
studi
warrant
focus
impact
introduc
molecular
diagnos
reduc
hospit
stay
andor
unnecessari
antimicrobi
use
